FDA

People at considerable risk of developing severe COVID-19, including millions of Americans with compromised immune systems, now have the option of receiving a preventive monoclonal antibody treatment if they have been or are at risk of being exposed to the coronavirus. The Food and Drug Administration’s action on Friday brings hope to the estimated 3% of Americans who are immunocompromised, including those with autoimmune...

The CDC is warning consumers not to taste or eat raw cake batter, whether it’s homemade or from a mix, because it could contain harmful bacteria.

The U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine.

The U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine.

McCormick has issued a nationwide voluntary recall of several seasoning products sold at retailers in the U.S., Canada and Bermuda due to possible salmonella contamination.

McCormick has issued a nationwide voluntary recall of several seasoning products sold at retailers in the U.S., Canada and Bermuda due to possible salmonella contamination.

A CDC advisory group is considering whether fully vaccinated Americans with weakened immune systems need a booster dose of the Covid vaccines.

The website insists that Subway tests its tuna regularly “to ensure it meets Subway’s stringent quality and safety requirements.”

Coronavirus vaccines aren’t likely to be available until midwinter, meaning that any child under the age of 12 will likely start the school year unvaccinated. NBC10’s Miguel Martinez-Valle reports.

The CDC confirmed Monday that about 100 cases of Guillain-Barré syndrome, a rare neurological disorder, were found in people who had received the Johnson & Johnson vaccine.

Pfizer is meeting with federal health officials Monday to discuss if and when Americans need Covid vaccine booster shots as it prepares to seek authorization.

Pfizer says it plans to meet Monday with top U.S. health officials to discuss the drugmaker’s request for federal authorization of a third dose of its COVID-19 vaccine

The acting head of the Food and Drug Administration is calling for a government investigation into highly unusual contacts between her agency’s drug reviewers and the maker of a controversial new Alzheimer’s drug

The Food and Drug Administration has approved new prescribing instructions that are likely to limit use of a controversial new Alzheimer’s drug

A month after approving a controversial new Alzheimer’s drug, the FDA has signed off on new prescribing instructions to limit its use to only patients with early or mild cases of the disease. The acting head of the FDA, Dr. Janet Woodcock, also announced that she was ordering an investigation into whether the agency acted improperly in approving the...

Doctors are trying to figure out who should get a new treatment for Alzheimer’s disease

You may not be ready to eat bugs, but would you feed insect-based protein to your pet to help fight climate change caused by the food industry?

Biogen Alzheimer’s drug Aduhelm is the first new treatment for dementia approved by the FDA in decades, and it’s started a war over the brain drug pipeline.

Moderna filed a request with the FDA to authorize its COVID-19 vaccine for use in adolescents ages 12 to 17.

If cleared by the FDA, it will become the second Covid-19 vaccine available in the United States for teens under 18 along with Pfizer-BioNTech’s vaccine, which was authorized for adolescents ages 12 to 15 in May.